Cargando…

Neoadjuvant Systemic Treatment of Primary Angiosarcoma

Angiosarcoma is an extremely rare and aggressive malignancy. Standard of care of localized tumors includes surgery ± radiation. Despite this multimodal treatment, >50% of the angiosarcoma patients develop local or distant recurrent disease. The role of neoadjuvant systemic therapy is still contro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heinhuis, Kimberley M., IJzerman, Nikki S., van der Graaf, Winette T. A., Kerst, Jan Martijn, Schrage, Yvonne, Beijnen, Jos H., Steeghs, Neeltje, van Houdt, Winan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464310/ https://www.ncbi.nlm.nih.gov/pubmed/32806524 http://dx.doi.org/10.3390/cancers12082251

Ejemplares similares

PropAngio study protocol: a neoadjuvant trial on the efficacy of propranolol monotherapy in cutaneous angiosarcoma—a proof of principle study
por: Heinhuis, Kimberley M, et al.
Publicado: (2020)

Liquid Biopsies in Sarcoma Clinical Practice: Where Do We Stand?
por: van der Laan, Pia, et al.
Publicado: (2021)

Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?
por: Embaby, Alaa, et al.
Publicado: (2022)

RNA-Sequencing of Tumor-Educated Platelets, a Novel Biomarker for Blood-Based Sarcoma Diagnostics
por: Heinhuis, Kimberley M., et al.
Publicado: (2020)

Desmoid is not a sarcoma; reply to Sachdev et al.
por: van der Graaf, Winette T.A., et al.
Publicado: (2023)

Central venous access related adverse events after trabectedin infusions in soft tissue sarcoma patients; experience and management in a nationwide multi-center study
por: Verboom, Michiel C., et al.
Publicado: (2017)

Survival and Cost-Effectiveness of Trabectedin Compared to Ifosfamide Monotherapy in Advanced Soft Tissue Sarcoma Patients
por: Verboom, Michiel C., et al.
Publicado: (2019)

Imatinib, sunitinib and pazopanib: From flat‐fixed dosing towards a pharmacokinetically guided personalized dose
por: Westerdijk, Kim, et al.
Publicado: (2020)

Prognostic Factors in a Large Nationwide Cohort of Histologically Confirmed Primary and Secondary Angiosarcomas
por: Weidema, Marije E., et al.
Publicado: (2019)

PARP inhibition in UV-associated angiosarcoma preclinical models
por: Weidema, Marije E., et al.
Publicado: (2021)

Gastrointestinal Stromal Tumours (GIST) in Young Adult (18–40 Years) Patients: A Report from the Dutch GIST Registry
por: IJzerman, Nikki S., et al.
Publicado: (2020)

Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing
por: Verheijen, Remy B., et al.
Publicado: (2017)

A Review of CYP3A Drug-Drug Interaction Studies: Practical Guidelines for Patients Using Targeted Oral Anticancer Drugs
por: Molenaar-Kuijsten, Laura, et al.
Publicado: (2021)

Diagnosed with a Rare Cancer: Experiences of Adult Sarcoma Survivors with the Healthcare System—Results from the SURVSARC Study
por: Drabbe, Cas, et al.
Publicado: (2021)

Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology
por: Verheijen, Remy B., et al.
Publicado: (2017)

Long-term safety and anti-tumour activity of olaparib monotherapy after combination with carboplatin and paclitaxel in patients with advanced breast, ovarian or fallopian tube cancer
por: van der Noll, Ruud, et al.
Publicado: (2015)

Metastatic Soft Tissue Sarcomas in Adolescents and Young Adults: A Specialist Center Experience
por: Younger, Eugenie, et al.
Publicado: (2020)

Health-Related Quality of Life and Side Effects in Gastrointestinal Stromal Tumor (GIST) Patients Treated with Tyrosine Kinase Inhibitors: A Systematic Review of the Literature
por: van de Wal, Deborah, et al.
Publicado: (2022)

Unraveling the Heterogeneity of Sarcoma Survivors’ Health-Related Quality of Life Regarding Primary Sarcoma Location: Results from the SURVSARC Study
por: van Eck, Ilse, et al.
Publicado: (2020)

Pharmacokinetic Optimization of Everolimus Dosing in Oncology: A Randomized Crossover Trial
por: Verheijen, Remy B., et al.
Publicado: (2017)

Desmoid fibromatosis through the patients’ eyes: time to change the focus and organisation of care?
por: Husson, Olga, et al.
Publicado: (2018)

Clinical Impact of Prospective Whole Genome Sequencing in Sarcoma Patients
por: Schipper, Luuk J., et al.
Publicado: (2022)

Ritonavir-Boosted Exposure of Kinase Inhibitors: an Open Label, Cross-over Pharmacokinetic Proof-of-Concept Trial with Erlotinib
por: Boosman, René J., et al.
Publicado: (2022)

Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study
por: Constantinidou, Anastasia, et al.
Publicado: (2020)

Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
por: van Erp, Anke E. M., et al.
Publicado: (2017)

Primary Cardiac Angiosarcoma
por: Kodali, Dhatri, et al.
Publicado: (2006)

Primary Splenic Angiosarcoma
por: Hamid, Kamran S., et al.
Publicado: (2010)

Primary renal angiosarcoma
por: Sabharwal, Sagar, et al.
Publicado: (2013)

Primary angiosarcoma of the breast
por: Bordoni, Daniele, et al.
Publicado: (2016)

Sample Bias in Web-Based Patient-Generated Health Data of Dutch Patients With Gastrointestinal Stromal Tumor: Survey Study
por: Dirkson, Anne, et al.
Publicado: (2022)

Development of a Disease-Specific Health-Related Quality of Life Questionnaire (DTF-QoL) for Patients with Desmoid-Type Fibromatosis
por: Schut, Anne-Rose W., et al.
Publicado: (2022)

Unraveling Desmoid-Type Fibromatosis-Specific Health-Related Quality of Life: Who Is at Risk for Poor Outcomes
por: Schut, Anne-Rose W., et al.
Publicado: (2022)

Determination of the absolute bioavailability of oral imatinib using a stable isotopically labeled intravenous imatinib-d8 microdose
por: Roosendaal, Jeroen, et al.
Publicado: (2020)

Successful surgical excision of primary right atrial angiosarcoma
por: Bouma, Wobbe, et al.
Publicado: (2011)

Symptoms reported by gastrointestinal stromal tumour (GIST) patients on imatinib treatment: combining questionnaire and forum data
por: den Hollander, Dide, et al.
Publicado: (2022)

Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data
por: Mohammadi, Mahmoud, et al.
Publicado: (2023)

The Evaluation of Health-Related Quality of Life Issues Experienced by Patients with Desmoid-Type Fibromatosis (The QUALIFIED Study)—A Protocol for an International Cohort Study
por: Schut, Anne-Rose W., et al.
Publicado: (2021)

Bilateral Primary Angiosarcoma of the Breast
por: Keshav, P., et al.
Publicado: (2013)

Multiple Primary Angiosarcomas of the Colon
por: Radić, Sonja, et al.
Publicado: (2021)

The Perceived Impact of Length of the Diagnostic Pathway Is Associated with Health-Related Quality of Life of Sarcoma Survivors: Results from the Dutch Nationwide SURVSARC Study
por: Soomers, Vicky L. M. N., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bv6h4e7vqlb5117hm615qa2390